Blinatumomab Versus Standard of Care Chemotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
Clinical trial NCT02013167 · TERMINATED
Trial details
- NCT number
- NCT02013167
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-03
- Primary completion
- 2015-12-29
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.